Bank of America Boosts Oscar Health (NYSE:OSCR) Price Target to $25.00

Oscar Health (NYSE:OSCR) had its target price hoisted by Bank of America from $22.00 to $25.00 in a research note published on Monday morning, Benzinga reports. They currently have a buy rating on the stock.

Several other equities analysts have also recently commented on the stock. Wells Fargo & Company boosted their target price on shares of Oscar Health from $20.00 to $24.00 and gave the company an overweight rating in a research report on Thursday, May 9th. TheStreet upgraded Oscar Health from a d rating to a c- rating in a research note on Wednesday, February 21st. The Goldman Sachs Group lifted their price target on Oscar Health from $16.00 to $21.00 and gave the company a neutral rating in a research note on Thursday, May 9th. Finally, Raymond James started coverage on Oscar Health in a research report on Friday, March 22nd. They set an outperform rating and a $20.00 price objective for the company. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of Moderate Buy and an average price target of $17.67.

Oscar Health Stock Down 4.6 %

NYSE OSCR opened at $22.21 on Monday. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.29. The company has a market cap of $5.27 billion, a price-to-earnings ratio of -55.52 and a beta of 1.66. The company has a 50 day moving average of $16.98 and a 200-day moving average of $13.23. Oscar Health has a 1-year low of $4.72 and a 1-year high of $23.44.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Tuesday, May 7th. The company reported $0.62 earnings per share for the quarter, beating the consensus estimate of $0.28 by $0.34. The firm had revenue of $2.14 billion during the quarter, compared to analysts’ expectations of $1.99 billion. Oscar Health had a negative return on equity of 5.77% and a negative net margin of 0.82%. The company’s quarterly revenue was up 45.8% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.18) EPS. On average, equities research analysts expect that Oscar Health will post -0.04 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Oscar Health

Large investors have recently modified their holdings of the business. Vanguard Group Inc. lifted its position in shares of Oscar Health by 2.4% in the 1st quarter. Vanguard Group Inc. now owns 14,582,762 shares of the company’s stock worth $216,846,000 after purchasing an additional 337,850 shares during the period. Formation8 GP LLC bought a new stake in Oscar Health during the fourth quarter valued at $47,480,000. Price T Rowe Associates Inc. MD grew its holdings in Oscar Health by 153.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company’s stock worth $59,156,000 after acquiring an additional 2,409,160 shares during the period. Dimensional Fund Advisors LP raised its position in shares of Oscar Health by 14.2% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,162,935 shares of the company’s stock worth $28,942,000 after acquiring an additional 392,837 shares in the last quarter. Finally, Gilder Gagnon Howe & Co. LLC lifted its stake in shares of Oscar Health by 21.0% in the 4th quarter. Gilder Gagnon Howe & Co. LLC now owns 2,830,947 shares of the company’s stock valued at $25,903,000 after purchasing an additional 491,861 shares during the period. Institutional investors own 75.70% of the company’s stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.